Genome-wide functions of PML-RARα in acute promyelocytic leukaemia.

S Saeed, C Logie, H G Stunnenberg, J H A Martens
Author Information
  1. S Saeed: Department of Molecular Biology, Faculty of Science, Nijmegen Centre for Molecular Life Sciences, Radboud University, 6500 HB Nijmegen, The Netherlands.

Abstract

PML-RAR (retinoic acid receptor)α is the hallmark protein of acute promyelocytic leukaemia, a highly malignant subtype of acute myeloid leukaemia that accounts for approximately 10% of all AML cases. Recently, several studies have been set out to obtain a comprehensive genome-wide view of the molecular actions of this chimeric protein. In this review, we highlight the new insights that arose from these studies, in particular focussing on newly identified PML-RARα target genes, its interplay with RXR and deregulation of epigenetic modifications.

References

  1. Cancer Cell. 2007 Jul;12(1):23-35 [PMID: 17613434]
  2. Cancer Cell. 2010 Feb 17;17(2):186-97 [PMID: 20159610]
  3. Blood. 1998 Oct 1;92(7):2244-51 [PMID: 9746761]
  4. EMBO J. 1993 Aug;12(8):3171-82 [PMID: 8393784]
  5. Nature. 1998 Feb 19;391(6669):815-8 [PMID: 9486655]
  6. Mol Cell Biol. 2000 Sep;20(17):6276-86 [PMID: 10938104]
  7. Cell. 1991 Aug 23;66(4):663-74 [PMID: 1652368]
  8. Cancer Cell. 2007 Jul;12(1):36-51 [PMID: 17613435]
  9. Nat Cell Biol. 2008 May;10(5):547-55 [PMID: 18408733]
  10. Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):14807-12 [PMID: 10611294]
  11. Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9345-9 [PMID: 8415704]
  12. Cold Spring Harb Perspect Biol. 2010 May;2(5):a000661 [PMID: 20452955]
  13. Leuk Lymphoma. 2004 Apr;45(4):639-48 [PMID: 15160934]
  14. Science. 1994 Sep 9;265(5178):1573-7 [PMID: 8079170]
  15. Mol Cell. 2000 May;5(5):811-20 [PMID: 10882117]
  16. Cancer Cell. 2007 Jun;11(6):513-25 [PMID: 17560333]
  17. Blood. 2006 Apr 15;107(8):3330-8 [PMID: 16352814]
  18. Mol Cell Biol. 2006 Feb;26(4):1288-96 [PMID: 16449642]
  19. Front Biosci (Landmark Ed). 2009 Jan 01;14:1684-707 [PMID: 19273155]
  20. Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7401-5 [PMID: 7638205]
  21. EMBO J. 1996 Oct 15;15(20):5647-58 [PMID: 8896458]
  22. Nat Rev Drug Discov. 2007 Oct;6(10):793-810 [PMID: 17906642]
  23. Hum Mol Genet. 2005 Apr 15;14 Spec No 1:R77-84 [PMID: 15809276]
  24. Science. 2002 Feb 8;295(5557):1079-82 [PMID: 11834837]
  25. Blood. 2008 Mar 1;111(5):2505-15 [PMID: 18299451]
  26. J Exp Med. 2004 Apr 19;199(8):1163-74 [PMID: 15096541]
  27. FEBS Lett. 2010 Jun 18;584(12):2662-9 [PMID: 20388510]
  28. Cell. 1991 Aug 23;66(4):675-84 [PMID: 1652369]
  29. Science. 2010 Apr 9;328(5975):240-3 [PMID: 20378816]
  30. Genes Dev. 2008 Aug 1;22(15):2085-92 [PMID: 18676813]
  31. Cancer Cell. 2010 Feb 17;17(2):173-85 [PMID: 20159609]
  32. Cell. 2004 May 28;117(5):663-76 [PMID: 15163413]
  33. Nature. 1998 Feb 19;391(6669):811-4 [PMID: 9486654]

MeSH Term

Animals
Epigenesis, Genetic
Genome, Human
Humans
Leukemia, Promyelocytic, Acute
Models, Biological
Oncogene Proteins, Fusion
Signal Transduction

Chemicals

Oncogene Proteins, Fusion
promyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein

Word Cloud

Created with Highcharts 10.0.0acuteleukaemiaproteinpromyelocyticstudiesPML-RARαPML-RARretinoicacidreceptorαhallmarkhighlymalignantsubtypemyeloidaccountsapproximately10%AMLcasesRecentlyseveralsetobtaincomprehensivegenome-wideviewmolecularactionschimericreviewhighlightnewinsightsaroseparticularfocussingnewlyidentifiedtargetgenesinterplayRXRderegulationepigeneticmodificationsGenome-widefunctions

Similar Articles

Cited By